Skip to content

Clinical Study on Acupoint Catgut Embedding for Simple Obesity Patients Based on Acupoint Effect

Clinical Study on Acupoint Catgut Embedding for Simple Obesity Patients Based on Acupoint Effect

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000650
Enrollment
Unknown
Registered
2025-04-06
Start date
2024-07-04
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple obesity

Interventions

Control group (non-acupoint catgut embedding group):Two groups of acupoints A and B were selected for embedding and interchangeably used. The main point of the non-meridian buried line group: the non-
Experimental group (acupoint catgut embedding group):Two groups of acupoints A and B were selected for embedding and interchangeably used. Acupoint embedding Group A: Zhongwan, Tianshu (double), Zusan

Sponsors

Pengpuzhen Community Health Service Center Jingan District Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for subjects: Diagnostic criteria 1) Body Mass Index (BMI): BMI = weight (kg) / height (m²). In February 2000 the World Health Organization (WHO) released "Redefinition and Management of Obesity in the Asia-Pacific Region" which proposed weight classification suggestions for Asian adults: BMI = 23 is considered overweight BMI between 23 and 24.9 is considered pre-obese BMI between 25 and 29.9 is classified as grade I obesity and BMI = 30 is classified as grade II obesity. 2) Waist circumference: The WHO also proposed that among Asian adults with the same BMI and waist circumference grades the risk of obesity complications is as follows: a waist circumference of = 90 cm for men and = 80 cm for women is the boundary. 2.1.2 Inclusion criteria 1) Patients who meet the above diagnostic criteria and are diagnosed with simple obesity; 2) Age: 18 to 55 years old; 3) Body Mass Index (BMI): 25 = BMI < 30; 4) Waist circumference: = 90 cm for men and = 80 cm for women; 5) For smokers included their smoking habits have not changed for at least 2 months [34]; 6) Voluntary acceptance of the above intervention methods. Note: Only patients who meet all six of the above criteria can be included in this study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1) Endocrine diseases (such as polycystic ovary syndrome Cushing's disease hypothyroidism etc.); 2)complicated with diabetes mellitus uncontrolled hypertension (systolic blood pressure =160mmHg diastolic blood pressure =100mmHg)[35] or severe lung heart liver kidney diseases; 3) with mental disorders a history of forced hospitalization for depression more than two depressive episodes or suicidal tendencies [36]; 4)a history of a clinically diagnosed eating disorder such as bulimia bulimia anorexia etc. with a weight fluctuation of more than 5Kg within the past three months; 5) history of bariatric surgery ; He had a history of adhesion after previous surgery . Those who had received acupoint catgut embedding therapy for weight loss; Participated in a clinical study for weight loss within the past 3 months ; 6)taking drugs known to affect weight or appetite in the past 3 months such as weight-loss drugs corticosteroids antidepressants antipsychotic drugs non-selective systemic antihistamines nicotine replacement drugs and hypoglycemic drugs; Or have plans to quit smoking and drinking; 7) Pregnant lactating and menopausal women; Women planning to become pregnant within 32 weeks; 8) Protein allergy and scar constitution; Suffering from skin diseases such as eczema and psoriasis; Coagulation dysfunction or taking anticoagulant drugs such as warfarin and heparin; 9) Unable to cooperate and adhere to the treatment during the treatment.

Design outcomes

Primary

MeasureTime frame
Body weight;Visceral fat thickness;Body mass index;Percentage of body fat;Abdominal subcutaneous fat thickness;Measurement of BLOOD LIPIDS;

Secondary

MeasureTime frame
Waist-hip ratio;Waist circumference;Hip circumference;

Countries

China

Contacts

Public ContactGUO Haoyu

Pengpuzhen Community Health Service Center Jingan District Shanghai

cmguohaoyu@163.com+86 189 1702 5812

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026